← Back to all trials
Completed
NCT05717101
Patient Registry in Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound Imaging
Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Sex: All
Ages: 18 Years – 99 Years
Enrollment: 4
Sponsor: Mayo Clinic
Location: United States
Summary
This study creates a patient registry of patients undergoing contrast-enhances-harmonic endoscopic ultrasound imaging.
In order to improve what doctors see on the ultrasound exam, sometimes intravenous contrast can be used to better emphasize the blood flow in a particular organ or lesion.
Creating a local database that can be used as a patients registry may help doctors keep track of all patients that undergo contrast-enhanced endoscopic ultrasound procedures and also to monitor for possible procedure adverse events.
Eligibility Criteria
Inclusion Criteria:Male and female patients aged 18 years to 99 years old who were undergo CE-EUS are eligible for study inclusionBased on clinical judgement of the advanced endoscopist will include those who present with lesions where increased microvasculature and perfusion visualization with contrast-enhanced harmonic endoscopic ultrasound imaging would be of beneficial for lesion characterizationClinical medical stability to undergo sedation for endoscopy and provide informed consentExclusion Criteria:Medical condition that preclude the patient from having an endoscopic procedurePatients who cannot provide adequate research authorizationPatients with known allergies to ultrasound contrast agentsPatient who did not receive contrast during endoscopic ultrasound (EUS) exams
Source: ClinicalTrials.gov (NCT05717101). StuddyBuddy aggregates publicly available trial information.
